{"id":25595,"date":"2025-03-15T10:03:40","date_gmt":"2025-03-15T05:03:40","guid":{"rendered":"https:\/\/bigbreakingwire.in\/?p=25595"},"modified":"2025-03-15T10:37:08","modified_gmt":"2025-03-15T05:07:08","slug":"cathie-wood-ark-invest-trades-march-14-2025","status":"publish","type":"post","link":"https:\/\/bigbreakingwire.in\/cathie-wood-ark-invest-trades-march-14-2025\/","title":{"rendered":"Cathie Wood\u2019s ARK Makes Big Moves: Sells UIPATH, Buys GITLAB and IBOTTA"},"content":{"rendered":"
<\/div>\n

Cathie Wood\u2019s ARK Invest made notable trades on Friday, March 14, 2025, adjusting its positions in several companies. The firm\u2019s ETFs engaged in both buying and selling, reflecting a strategic shift in its holdings.<\/p>\n\n\n\n

Major Sale: UIPATH Inc.<\/strong><\/p>\n\n\n\n

The most significant transaction of the day was ARK\u2019s decision to sell shares of UIPATH Inc. The firm offloaded a total of 1,250,919 shares through its ARKK and ARKW ETFs, generating around $12.47 million in cash. This sale follows a pattern, as ARK has been consistently reducing its investment in UIPATH over the past week.<\/p>\n\n\n\n

GITLAB Inc. Sees Increased Investment<\/strong><\/p>\n\n\n\n

While ARK trimmed its UIPATH stake, it increased its holdings in GITLAB Inc. The firm purchased 104,153 shares through ARKK and ARKW ETFs, investing more than $5.2 million in the company. This move follows another GITLAB purchase just a day earlier, indicating ARK\u2019s confidence in the stock.<\/p>\n\n\n\n

Continued Accumulation of IBOTTA Shares<\/strong><\/p>\n\n\n\n

ARK also expanded its position in IBOTTA Inc., buying 79,201 shares through ARKW and ARKF ETFs. The total purchase value stood at $3.17 million. This marks another step in ARK\u2019s ongoing accumulation of IBOTTA shares over multiple trading sessions.<\/p>\n\n\n\n

Investment in Gene-Editing Company INTELLIA<\/strong><\/p>\n\n\n\n

Another company that gained ARK\u2019s attention was INTELLIA Therapeutics Inc., a player in the gene-editing industry. The firm purchased 67,520 shares through ARKK and ARKG ETFs, investing approximately $622,534 in the company.<\/p>\n\n\n\n

Other Key Trades: Roblox, CareDx, and More<\/strong><\/p>\n\n\n\n

On the selling side, ARK divested 47,153 shares of CareDx Inc. through its ARKG ETF, cashing in around $831,778. Additionally, it sold 46,026 shares of Prime Medicine Inc. via ARKK ETF for approximately $79,164.<\/p>\n\n\n\n

Another notable sale involved Roblox Corp., with ARK selling 38,757 shares through ARKW and ARKF ETFs, bringing in nearly $2.16 million. The firm also reduced its stake in Repare Therapeutics Inc., selling 53,449 shares through ARKG ETF for around $59,862.<\/p>\n\n\n\n

ARK\u2019s Evolving Strategy<\/strong><\/p>\n\n\n\n

These trades highlight ARK\u2019s evolving investment approach, adjusting its portfolio based on market trends and long-term vision. As investors closely follow Cathie Wood\u2019s moves, the latest transactions provide insight into the firm\u2019s strategic thinking and where it sees future potential.
<\/p>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

Cathie Wood\u2019s ARK Invest made notable trades on Friday, March 14, 2025, adjusting its positions in several companies. The firm\u2019s ETFs engaged in both buying…<\/p>\n","protected":false},"author":1,"featured_media":25594,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_lmt_disableupdate":"","_lmt_disable":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","enabled":false},"version":2}},"categories":[619],"tags":[509,510],"class_list":["post-25595","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-stocks-in-news","tag-arkk-investment","tag-cathie-wood","entry","rows"],"jetpack_publicize_connections":[],"modified_by":"bigbreakingwire","jetpack_featured_media_url":"https:\/\/bigbreakingwire.in\/wp-content\/uploads\/2025\/03\/pexels-photo-186464.webp","jetpack_shortlink":"https:\/\/wp.me\/pfgCxS-6EP","jetpack_sharing_enabled":true,"jetpack_likes_enabled":false,"_links":{"self":[{"href":"https:\/\/bigbreakingwire.in\/wp-json\/wp\/v2\/posts\/25595","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bigbreakingwire.in\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bigbreakingwire.in\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bigbreakingwire.in\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bigbreakingwire.in\/wp-json\/wp\/v2\/comments?post=25595"}],"version-history":[{"count":1,"href":"https:\/\/bigbreakingwire.in\/wp-json\/wp\/v2\/posts\/25595\/revisions"}],"predecessor-version":[{"id":25596,"href":"https:\/\/bigbreakingwire.in\/wp-json\/wp\/v2\/posts\/25595\/revisions\/25596"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/bigbreakingwire.in\/wp-json\/wp\/v2\/media\/25594"}],"wp:attachment":[{"href":"https:\/\/bigbreakingwire.in\/wp-json\/wp\/v2\/media?parent=25595"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bigbreakingwire.in\/wp-json\/wp\/v2\/categories?post=25595"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bigbreakingwire.in\/wp-json\/wp\/v2\/tags?post=25595"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}